1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Excellergy Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Find a Suitable Dose of Exl-111 for Further Research Exl-111 (SAD), Exl-111 (MAD), Placebo - Allergic Disease | Phase 1 | Recruiting | Excellergy Inc. | 70 | 2026-01-08 | 2026-09-22 |
Omalizumab (1) · Sagittal Abdominal Diameter (1) · mycophenolic adenine dinucleotide (1)
Australia (1) · New Zealand (1)